Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register
Crossref DOI link: https://doi.org/10.1186/s12891-016-1192-7
Published Online: 2016-08-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McWilliams, Daniel F.
Walsh, David A.
Funding for this research was provided by:
Pfizer UK (WI190792)
License valid from 2016-08-12